Ginkgo Bioworks Holdings (DNA) Gross Margin Growth (1y) (2021 - 2026)

Ginkgo Bioworks Holdings (DNA) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ginkgo Bioworks Holdings 517.16 Mn 373.30 Mn 16.38 Mn -521.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -521.00
Dec 31, 2025 -5,193.00
Sep 30, 2025 -1,879.00
Jun 30, 2025 -744.00
Mar 31, 2025 -1,070.00
Dec 31, 2024 -780.00
Sep 30, 2024 1,023.00
Jun 30, 2024 1,653.00
Mar 31, 2024 2,210.00
Dec 31, 2023 -15,295.00
Sep 30, 2023 2,464.00
Jun 30, 2023 -1,825.00
Mar 31, 2023 -1,729.00
Dec 31, 2022 15,928.00
Sep 30, 2022 -1,282.00
Jun 30, 2022 3,335.00
Mar 31, 2022 2,641.00
Dec 31, 2021 2,453.00
Sep 30, 2021 -2,432.00